- A U.S. appeals court has cleared the way for Novartis AG to launch the first biosimilar drug in the United States as it declined on Wednesday to stop the sale of the company's copycat version of Amgen Inc's blockbuster cancer drug Neupogen.
(Reuters Health) - Living kidney donors and their recipients would like to share more health information before the transplant surgery, a new survey indicates.
LONDON - Medical researchers called on Wednesday for detailed, thoughtful debate on future use of new genetic technology that has the potential to create "designer babies".
(Reuters Health) - In a long-term study of older men diagnosed with low-risk prostate cancer and followed with so-called active surveillance, less than a third of cases eventually needed treatment, according to a new study.
- Gilead Sciences Inc said on Wednesday its experimental fixed-dose combination treatment for HIV proved as effective in a late-stage study as the company's widely used Truvada combo pill but with significantly less loss of bone mineral density and kidney function.
GENEVA - Two children in southwestern Ukraine have been paralyzed by polio, the first outbreak of the disease in Europe since 2010, the World Health Organization said on Wednesday, in a setback for a global eradication campaign.
- The U.S. Food and Drug Administration approved Tesaro Inc's treatment for chemotherapy-induced nausea and vomiting in adults, the company said on Wednesday.
CUTTACK, India - Sixty-one infants have died at an Indian children's hospital in just two weeks, sparking protests and forcing the state government to launch an investigation.
(Reuters Health) - Advances in genetic testing may eventually allow for more tailored care for people with an autism spectrum disorder (ASD), researchers say.
NEW YORK - In another setback for prominent hedge fund manager Kyle Bass and his campaign to eliminate some drug patents, the U.S. Patent and Trademark Office on Wednesday declined to hold a trial on the validity of a patent on Biogen Inc's multiple sclerosis drug Tecfidera.